APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaler Devices for Respiratory Medicines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inhaler Devices for Respiratory Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchInhaler Devices for Respiratory Medicines Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaler Devices for Respiratory Medicines Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Inhaler Devices for Respiratory Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaler Devices for Respiratory Medicines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaler Devices for Respiratory Medicines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Inhaler Devices for Respiratory Medicines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Inhaler Devices for Respiratory Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhaler Devices for Respiratory Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhaler Devices for Respiratory Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inhaler Devices for Respiratory Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhaler Devices for Respiratory Medicines include Novartis, Viatris, Mylan, AstraZeneca, Vectura, Teva Pharmaceutical Industries, PARI International, OMRON and Monaghan Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhaler Devices for Respiratory Medicines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhaler Devices for Respiratory Medicines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhaler Devices for Respiratory Medicines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhaler Devices for Respiratory Medicines market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhaler Devices for Respiratory Medicines Segment by Company

Novartis

Viatris

Mylan

AstraZeneca

Vectura

Teva Pharmaceutical Industries

PARI International

OMRON

Monaghan Medical

Koninklijke Philips

H&T Presspart

GlaxoSmithKline (GSK)

Chiesi Farmaceutici

Boehringer Ingelheim

AptarGroup

Inhaler Devices for Respiratory Medicines Segment by Type

Metered- dose Inhalers

Dry-powder Inhalers

Nebulizers

Inhaler Devices for Respiratory Medicines Segment by Application

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis (CF)

Idiopathic Pulmonary Fibrosis (IPF)

Asthma

Others

Inhaler Devices for Respiratory Medicines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaler Devices for Respiratory Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaler Devices for Respiratory Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaler Devices for Respiratory Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhaler Devices for Respiratory Medicines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhaler Devices for Respiratory Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inhaler Devices for Respiratory Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inhaler Devices for Respiratory Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inhaler Devices for Respiratory Medicines Industry Trends Table 2. Inhaler Devices for Respiratory Medicines Industry Drivers Table 3. Inhaler Devices for Respiratory Medicines Industry Opportunities and Challenges Table 4. Inhaler Devices for Respiratory Medicines Industry Restraints Table 5. Global Inhaler Devices for Respiratory Medicines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inhaler Devices for Respiratory Medicines Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Manufacturers Table 9. Global Inhaler Devices for Respiratory Medicines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Inhaler Devices for Respiratory Medicines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inhaler Devices for Respiratory Medicines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inhaler Devices for Respiratory Medicines Manufacturers, Product Type & Application Table 13. Global Inhaler Devices for Respiratory Medicines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhaler Devices for Respiratory Medicines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Metered- dose Inhalers Table 17. Major Manufacturers of Dry-powder Inhalers Table 18. Major Manufacturers of Nebulizers Table 19. Global Inhaler Devices for Respiratory Medicines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Inhaler Devices for Respiratory Medicines Sales by Type (2021-2026) & (K Units) Table 21. Global Inhaler Devices for Respiratory Medicines Sales by Type (2027-2032) & (K Units) Table 22. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2021-2026) Table 23. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2027-2032) Table 24. Global Inhaler Devices for Respiratory Medicines Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Inhaler Devices for Respiratory Medicines Revenue by Type (2021-2026) & (K Units) Table 26. Global Inhaler Devices for Respiratory Medicines Revenue by Type (2027-2032) & (K Units) Table 27. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2021-2026) Table 28. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Chronic Obstructive Pulmonary Disease (COPD) Table 30. Major Manufacturers of Cystic Fibrosis (CF) Table 31. Major Manufacturers of Idiopathic Pulmonary Fibrosis (IPF) Table 32. Major Manufacturers of Asthma Table 33. Major Manufacturers of Others Table 34. Global Inhaler Devices for Respiratory Medicines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Inhaler Devices for Respiratory Medicines Sales by Application (2021-2026) & (K Units) Table 36. Global Inhaler Devices for Respiratory Medicines Sales by Application (2027-2032) & (K Units) Table 37. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2021-2026) Table 38. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2027-2032) Table 39. Global Inhaler Devices for Respiratory Medicines Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Inhaler Devices for Respiratory Medicines Revenue by Application (2021-2026) & (K Units) Table 41. Global Inhaler Devices for Respiratory Medicines Revenue by Application (2027-2032) & (K Units) Table 42. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2021-2026) Table 43. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2027-2032) Table 44. Global Inhaler Devices for Respiratory Medicines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Inhaler Devices for Respiratory Medicines Sales by Region (2021-2026) & (K Units) Table 46. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2021-2026) Table 47. Global Inhaler Devices for Respiratory Medicines Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Inhaler Devices for Respiratory Medicines Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026) & (K Units) Table 51. North America Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032) & (K Units) Table 52. Europe Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026) & (K Units) Table 54. Europe Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032) & (K Units) Table 61. Global Inhaler Devices for Respiratory Medicines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Inhaler Devices for Respiratory Medicines Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Inhaler Devices for Respiratory Medicines Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2021-2026) Table 65. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2027-2032) Table 66. Novartis Company Information Table 67. Novartis Business Overview Table 68. Novartis Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Novartis Inhaler Devices for Respiratory Medicines Product Portfolio Table 70. Novartis Recent Development Table 71. Viatris Company Information Table 72. Viatris Business Overview Table 73. Viatris Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Viatris Inhaler Devices for Respiratory Medicines Product Portfolio Table 75. Viatris Recent Development Table 76. Mylan Company Information Table 77. Mylan Business Overview Table 78. Mylan Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Mylan Inhaler Devices for Respiratory Medicines Product Portfolio Table 80. Mylan Recent Development Table 81. AstraZeneca Company Information Table 82. AstraZeneca Business Overview Table 83. AstraZeneca Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. AstraZeneca Inhaler Devices for Respiratory Medicines Product Portfolio Table 85. AstraZeneca Recent Development Table 86. Vectura Company Information Table 87. Vectura Business Overview Table 88. Vectura Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Vectura Inhaler Devices for Respiratory Medicines Product Portfolio Table 90. Vectura Recent Development Table 91. Teva Pharmaceutical Industries Company Information Table 92. Teva Pharmaceutical Industries Business Overview Table 93. Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Product Portfolio Table 95. Teva Pharmaceutical Industries Recent Development Table 96. PARI International Company Information Table 97. PARI International Business Overview Table 98. PARI International Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. PARI International Inhaler Devices for Respiratory Medicines Product Portfolio Table 100. PARI International Recent Development Table 101. OMRON Company Information Table 102. OMRON Business Overview Table 103. OMRON Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. OMRON Inhaler Devices for Respiratory Medicines Product Portfolio Table 105. OMRON Recent Development Table 106. Monaghan Medical Company Information Table 107. Monaghan Medical Business Overview Table 108. Monaghan Medical Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Monaghan Medical Inhaler Devices for Respiratory Medicines Product Portfolio Table 110. Monaghan Medical Recent Development Table 111. Koninklijke Philips Company Information Table 112. Koninklijke Philips Business Overview Table 113. Koninklijke Philips Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Koninklijke Philips Inhaler Devices for Respiratory Medicines Product Portfolio Table 115. Koninklijke Philips Recent Development Table 116. H&T Presspart Company Information Table 117. H&T Presspart Business Overview Table 118. H&T Presspart Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. H&T Presspart Inhaler Devices for Respiratory Medicines Product Portfolio Table 120. H&T Presspart Recent Development Table 121. GlaxoSmithKline (GSK) Company Information Table 122. GlaxoSmithKline (GSK) Business Overview Table 123. GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Product Portfolio Table 125. GlaxoSmithKline (GSK) Recent Development Table 126. Chiesi Farmaceutici Company Information Table 127. Chiesi Farmaceutici Business Overview Table 128. Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Product Portfolio Table 130. Chiesi Farmaceutici Recent Development Table 131. Boehringer Ingelheim Company Information Table 132. Boehringer Ingelheim Business Overview Table 133. Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Product Portfolio Table 135. Boehringer Ingelheim Recent Development Table 136. AptarGroup Company Information Table 137. AptarGroup Business Overview Table 138. AptarGroup Inhaler Devices for Respiratory Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. AptarGroup Inhaler Devices for Respiratory Medicines Product Portfolio Table 140. AptarGroup Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Inhaler Devices for Respiratory Medicines Distributors List Table 144. Inhaler Devices for Respiratory Medicines Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Inhaler Devices for Respiratory Medicines Product Image Figure 2. Global Inhaler Devices for Respiratory Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaler Devices for Respiratory Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhaler Devices for Respiratory Medicines Sales (2021-2032) & (K Units) Figure 5. Global Inhaler Devices for Respiratory Medicines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Inhaler Devices for Respiratory Medicines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Metered- dose Inhalers Image Figure 9. Dry-powder Inhalers Image Figure 10. Nebulizers Image Figure 11. Global Inhaler Devices for Respiratory Medicines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Inhaler Devices for Respiratory Medicines Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2021-2032) Figure 14. Global Inhaler Devices for Respiratory Medicines Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Inhaler Devices for Respiratory Medicines Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2021-2032) Figure 17. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 18. Cystic Fibrosis (CF) Image Figure 19. Idiopathic Pulmonary Fibrosis (IPF) Image Figure 20. Asthma Image Figure 21. Others Image Figure 22. Global Inhaler Devices for Respiratory Medicines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Inhaler Devices for Respiratory Medicines Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2021-2032) Figure 25. Global Inhaler Devices for Respiratory Medicines Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Inhaler Devices for Respiratory Medicines Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2021-2032) Figure 28. North America Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021-2032) Figure 30. U.S. Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021-2032) Figure 35. Germany Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021-2032) Figure 42. China Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021-2032) Figure 50. Brazil Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Inhaler Devices for Respiratory Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Inhaler Devices for Respiratory Medicines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Inhaler Devices for Respiratory Medicines Revenue (2021-2032) & (US$ Million) Figure 61. North America Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Inhaler Devices for Respiratory Medicines Revenue (2021-2032) & (US$ Million) Figure 63. Europe Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Inhaler Devices for Respiratory Medicines Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Inhaler Devices for Respiratory Medicines Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Inhaler Devices for Respiratory Medicines Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Metered- dose Inhalers
  • Dry-powder Inhalers
  • Nebulizers
Applications
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Asthma
  • Others
Companies covered
  • Novartis
  • Viatris
  • Mylan
  • AstraZeneca
  • Vectura
  • Teva Pharmaceutical Industries
  • PARI International
  • OMRON
  • Monaghan Medical
  • Koninklijke Philips
  • H&T Presspart
  • GlaxoSmithKline (GSK)
  • Chiesi Farmaceutici
  • Boehringer Ingelheim
  • AptarGroup

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inhaler Devices for Respiratory Medicines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inhaler Devices for Respiratory Medicines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inhaler Devices for Respiratory Medicines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inhaler Devices for Respiratory Medicines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inhaler Devices for Respiratory Medicines Market Dynamics
  1. 2.1 Inhaler Devices for Respiratory Medicines Industry Trends
  2. 2.2 Inhaler Devices for Respiratory Medicines Industry Drivers
  3. 2.3 Inhaler Devices for Respiratory Medicines Industry Opportunities and Challenges
  4. 2.4 Inhaler Devices for Respiratory Medicines Industry Restraints
3 Inhaler Devices for Respiratory Medicines Market by Manufacturers
  1. 3.1 Global Inhaler Devices for Respiratory Medicines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inhaler Devices for Respiratory Medicines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inhaler Devices for Respiratory Medicines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inhaler Devices for Respiratory Medicines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhaler Devices for Respiratory Medicines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inhaler Devices for Respiratory Medicines Manufacturers, Product Type & Application
  7. 3.7 Global Inhaler Devices for Respiratory Medicines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhaler Devices for Respiratory Medicines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhaler Devices for Respiratory Medicines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhaler Devices for Respiratory Medicines Tier 1, Tier 2, and Tier 3
4 Inhaler Devices for Respiratory Medicines Market by Type
  1. 4.1 Inhaler Devices for Respiratory Medicines Type Introduction
  2. 4.1.1 Metered- dose Inhalers
  3. 4.1.2 Dry-powder Inhalers
  4. 4.1.3 Nebulizers
  5. 4.2 Global Inhaler Devices for Respiratory Medicines Sales by Type
  6. 4.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhaler Devices for Respiratory Medicines Sales by Type (2021-2032)
  8. 4.2.3 Global Inhaler Devices for Respiratory Medicines Sales Market Share by Type (2021-2032)
  9. 4.3 Global Inhaler Devices for Respiratory Medicines Revenue by Type
  10. 4.3.1 Global Inhaler Devices for Respiratory Medicines Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhaler Devices for Respiratory Medicines Revenue by Type (2021-2032)
  12. 4.3.3 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Type (2021-2032)
5 Inhaler Devices for Respiratory Medicines Market by Application
  1. 5.1 Inhaler Devices for Respiratory Medicines Application Introduction
  2. 5.1.1 Chronic Obstructive Pulmonary Disease (COPD)
  3. 5.1.2 Cystic Fibrosis (CF)
  4. 5.1.3 Idiopathic Pulmonary Fibrosis (IPF)
  5. 5.1.4 Asthma
  6. 5.1.5 Others
  7. 5.2 Global Inhaler Devices for Respiratory Medicines Sales by Application
  8. 5.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Inhaler Devices for Respiratory Medicines Sales by Application (2021-2032)
  10. 5.2.3 Global Inhaler Devices for Respiratory Medicines Sales Market Share by Application (2021-2032)
  11. 5.3 Global Inhaler Devices for Respiratory Medicines Revenue by Application
  12. 5.3.1 Global Inhaler Devices for Respiratory Medicines Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Inhaler Devices for Respiratory Medicines Revenue by Application (2021-2032)
  14. 5.3.3 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Application (2021-2032)
6 Global Inhaler Devices for Respiratory Medicines Sales by Region
  1. 6.1 Global Inhaler Devices for Respiratory Medicines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhaler Devices for Respiratory Medicines Sales by Region (2021-2032)
  3. 6.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Region (2021-2026)
  4. 6.2.2 Global Inhaler Devices for Respiratory Medicines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inhaler Devices for Respiratory Medicines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inhaler Devices for Respiratory Medicines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inhaler Devices for Respiratory Medicines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inhaler Devices for Respiratory Medicines Revenue by Region
  1. 7.1 Global Inhaler Devices for Respiratory Medicines Revenue by Region
  2. 7.1.1 Global Inhaler Devices for Respiratory Medicines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inhaler Devices for Respiratory Medicines Revenue by Region (2021-2026)
  4. 7.1.3 Global Inhaler Devices for Respiratory Medicines Revenue by Region (2027-2032)
  5. 7.1.4 Global Inhaler Devices for Respiratory Medicines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inhaler Devices for Respiratory Medicines Revenue (2021-2032)
  8. 7.2.2 North America Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inhaler Devices for Respiratory Medicines Revenue (2021-2032)
  11. 7.3.2 Europe Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inhaler Devices for Respiratory Medicines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inhaler Devices for Respiratory Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Inhaler Devices for Respiratory Medicines Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Viatris
  8. 8.2.1 Viatris Company Information
  9. 8.2.2 Viatris Business Overview
  10. 8.2.3 Viatris Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Viatris Inhaler Devices for Respiratory Medicines Product Portfolio
  12. 8.2.5 Viatris Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Inhaler Devices for Respiratory Medicines Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Inhaler Devices for Respiratory Medicines Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Vectura
  26. 8.5.1 Vectura Company Information
  27. 8.5.2 Vectura Business Overview
  28. 8.5.3 Vectura Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vectura Inhaler Devices for Respiratory Medicines Product Portfolio
  30. 8.5.5 Vectura Recent Developments
  31. 8.6 Teva Pharmaceutical Industries
  32. 8.6.1 Teva Pharmaceutical Industries Company Information
  33. 8.6.2 Teva Pharmaceutical Industries Business Overview
  34. 8.6.3 Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Product Portfolio
  36. 8.6.5 Teva Pharmaceutical Industries Recent Developments
  37. 8.7 PARI International
  38. 8.7.1 PARI International Company Information
  39. 8.7.2 PARI International Business Overview
  40. 8.7.3 PARI International Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PARI International Inhaler Devices for Respiratory Medicines Product Portfolio
  42. 8.7.5 PARI International Recent Developments
  43. 8.8 OMRON
  44. 8.8.1 OMRON Company Information
  45. 8.8.2 OMRON Business Overview
  46. 8.8.3 OMRON Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 OMRON Inhaler Devices for Respiratory Medicines Product Portfolio
  48. 8.8.5 OMRON Recent Developments
  49. 8.9 Monaghan Medical
  50. 8.9.1 Monaghan Medical Company Information
  51. 8.9.2 Monaghan Medical Business Overview
  52. 8.9.3 Monaghan Medical Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Monaghan Medical Inhaler Devices for Respiratory Medicines Product Portfolio
  54. 8.9.5 Monaghan Medical Recent Developments
  55. 8.10 Koninklijke Philips
  56. 8.10.1 Koninklijke Philips Company Information
  57. 8.10.2 Koninklijke Philips Business Overview
  58. 8.10.3 Koninklijke Philips Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Koninklijke Philips Inhaler Devices for Respiratory Medicines Product Portfolio
  60. 8.10.5 Koninklijke Philips Recent Developments
  61. 8.11 H&T Presspart
  62. 8.11.1 H&T Presspart Company Information
  63. 8.11.2 H&T Presspart Business Overview
  64. 8.11.3 H&T Presspart Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 H&T Presspart Inhaler Devices for Respiratory Medicines Product Portfolio
  66. 8.11.5 H&T Presspart Recent Developments
  67. 8.12 GlaxoSmithKline (GSK)
  68. 8.12.1 GlaxoSmithKline (GSK) Company Information
  69. 8.12.2 GlaxoSmithKline (GSK) Business Overview
  70. 8.12.3 GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Product Portfolio
  72. 8.12.5 GlaxoSmithKline (GSK) Recent Developments
  73. 8.13 Chiesi Farmaceutici
  74. 8.13.1 Chiesi Farmaceutici Company Information
  75. 8.13.2 Chiesi Farmaceutici Business Overview
  76. 8.13.3 Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Product Portfolio
  78. 8.13.5 Chiesi Farmaceutici Recent Developments
  79. 8.14 Boehringer Ingelheim
  80. 8.14.1 Boehringer Ingelheim Company Information
  81. 8.14.2 Boehringer Ingelheim Business Overview
  82. 8.14.3 Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Recent Developments
  85. 8.15 AptarGroup
  86. 8.15.1 AptarGroup Company Information
  87. 8.15.2 AptarGroup Business Overview
  88. 8.15.3 AptarGroup Inhaler Devices for Respiratory Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AptarGroup Inhaler Devices for Respiratory Medicines Product Portfolio
  90. 8.15.5 AptarGroup Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhaler Devices for Respiratory Medicines Value Chain Analysis
  2. 9.1.1 Inhaler Devices for Respiratory Medicines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhaler Devices for Respiratory Medicines Production Mode & Process
  6. 9.2 Inhaler Devices for Respiratory Medicines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhaler Devices for Respiratory Medicines Distributors
  9. 9.2.3 Inhaler Devices for Respiratory Medicines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst